Company Filing History:
Years Active: 2019-2022
Title: Xinzhi Wang: Innovator in Biotechnology from Guangdong, CN
Introduction: Xinzhi Wang is a prominent inventor based in Guangdong, China, known for his significant contributions to the field of biotechnology. With a total of three patents to his name, he has played a crucial role in advancing pharmaceutical compositions that utilize recombinant human-basic fibroblast growth factor (rh-bFGF).
Latest Patents: Wang's latest patents include groundbreaking innovations that focus on rh-bFGF. The first patent provides a mutated nucleic acid molecule and a pharmaceutical composition comprising rh-bFGF, detailing its various uses. The second patent outlines a method for producing soluble recombinant human-basic fibroblast growth factor, along with a mutated nucleic acid molecule encoding this important growth factor.
Career Highlights: Xinzhi Wang currently works at Zhuhai Essex Bio-pharmaceutical Co., Ltd., where he continues to advance research in biopharmaceuticals. His work has brought forth significant advancements that have potential applications in regenerative medicine and other areas of healthcare.
Collaborations: Throughout his career, Wang has collaborated with notable colleagues, including Haizhou Fang and Peimin Dai, who have contributed to the development and realization of his innovative ideas. Together, they form a team dedicated to research and development in the field of pharmaceuticals.
Conclusion: Xinzhi Wang stands out as a key figure in the biotechnology sector, pushing the boundaries of innovation with his patents and research at Zhuhai Essex Bio-pharmaceutical Co., Ltd. His work on recombinant human-basic fibroblast growth factor demonstrates the crucial link between scientific research and practical applications in medicine, marking him as an inventor to watch in the years to come.